ITP - Immune Thrombocytopenia

Hematology

Prevalence

30.0 / 100K

0 drugs in development·0 companies·3 clinical trials

Frequently asked questions

How many clinical trials target ITP - Immune Thrombocytopenia?

There are 3 clinical trials targeting ITP - Immune Thrombocytopenia tracked by BioSniper.

What is the prevalence of ITP - Immune Thrombocytopenia?

The estimated prevalence of ITP - Immune Thrombocytopenia is approximately 30.0 per 100,000 population.

Deep-dive into ITP - Immune Thrombocytopenia

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    ITP - Immune Thrombocytopenia — Drugs in Development & Clinical Trials | BioSniper